Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Kos Settlement Keeps Barr’s Generic Niaspan, Advicor Off Market Until 2013

Apr 13 2005

• By Steele Thomas

Related Content

Barr To Co-Promote Kos' Anti-Cholesterol Products Under Settlement

Apr 13 2005

Zyprexa Patent Verdict Coming April 14

Apr 13 2005

Paxil Patent Ruling Revised: Will GSK’s Loss Be A Gain For Lilly’s Zyprexa?

Apr 08 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window